Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$8.12 USD
-0.18 (-2.17%)
Updated May 3, 2024 04:00 PM ET
After-Market: $8.11 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Brokerage Reports
0 items in cart
Ironwood Pharmaceuticals, Inc. [IRWD]
Reports for Purchase
Showing records 101 - 120 ( 1015 total )
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
We are dropping coverage due to realignment of analyst resources
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker - Week Ended August 23
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
2Q19 Financial Results Reported; Revenue Guidance Maintained; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker - Week Ended July 26
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Q2:19; Positive Demand Growth and Profitability Weighed by Pricing Pressure
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology - Recent Drug Launch Weekly Retail Sales Tracker - Week Ended July 5
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Retail Prescription Sales Tracker - Constipation Drugs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D